Premium
Low‐dose vemurafenib in hairy cell leukemia patients with active infection
Author(s) -
Bohn JanPaul,
Pircher Andreas,
Wanner David,
Vill David,
Foeger Bernhard,
Wolf Dominik,
Steurer Michael
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25474
Subject(s) - vemurafenib , cladribine , medicine , purine analogue , hairy cell leukemia , rituximab , adverse effect , gastroenterology , leukemia , surgery , dermatology , oncology , lymphoma , purine , cancer , biochemistry , chemistry , enzyme , metastatic melanoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom